The ubiquitous intracellular protease dipeptidyl peptidase 9 (DPP9) has roles in antigen presentation and B cell signaling. To investigate the importance of DPP9 in immune regeneration, primary and secondary chimeric mice were created in irradiated recipients using fetal liver cells and adult bone marrow cells, respectively, using wildtype (WT) and DPP9 gene-knockin (DPP9 S729A ) enzyme-inactive mice. Immune cell reconstitution was assessed at 6 and 16 weeks post-transplant. Primary chimeric mice successfully regenerated neutrophils, natural killer, T and B cells, irrespective of donor cell genotype. There were no significant differences in total myeloid cell or neutrophil numbers between DPP9-WT and DPP9 S729A -reconstituted mice. There were fewer B cells in the DPP9 S729A -origin compared to DPP9 WT-origin mice in primary chimeric mice. In secondary chimeric mice, cells of DPP9 S729A -origin cells displayed enhanced engraftment compared to WT. However, we observed no differences in myeloid or lymphoid lineage reconstitution between WT and DPP9 S729A donors, indicating that hematopoietic stem cell (HSC) engraftment and self-renewal is not diminished by the absence of DPP9 enzymatic activity. This is the first report on transplantation of bone marrow cells that lack DPP9 enzymatic activity.
Introduction
The ubiquitous intracellular post-proline serine protease dipeptidyl peptidase 9 (DPP9) belongs to the DPP4 gene family, which includes four atypical serine proteases: DPP4, fibroblast activation protein (FAP), DPP8 and DPP9 1, 2 . DPP9 plays roles in both innate and adaptive immunity. DPP9 is extensively expressed throughout immunological tissues in vivo 3 and within individual leukocyte subpopulations 1, [4] [5] [6] [7] [8] [9] . DPP9 mRNA and protein is up-regulated in stimulated mouse splenocytes and in Jurkat T-and Raji Bcell lines 6 . Endogenous DPP9 limits the presentation of an antigenic peptide, RU134-42, through cleaving this peptide 10 . DPP9 causes Syk degradation and thus influences Syk signalling in B cells 8 . Activation and proliferation of innate and adaptive immune cells is diminished in the absence of DPP9 enzymatic activity 4, 9, 11, 12 . Within monocytes and macrophages, basal DPP8 and DPP9 activity suppresses inflammasome activation through inhibition of pro-caspase-1 activation via NLRP-1 13, 14 . Thus, a variety of evidence supports multiple roles for DPP9 in the regulation of immune function.
We generated the first gene DPP9 knock-in (DPP9 S729A ) mouse that has a single serine-to-alanine point mutation at the enzyme active site (S729A) 15 . Unlike mice deficient in any other protease of this gene family, homozygote DPP9 deficiency is neonate lethal [15] [16] [17] . DPP9 is closely related to the extracellular proteases DPP4 (CD26) and fibroblast activation protein (FAP) 18 . DPP4 is expressed by immune cells of both the myeloid and lymphoid lineages 19 20 . Genetic or pharmacologic ablation of DPP4 improves bone marrow engraftment 21 . We found that FAP expression does not influence the proportions of CD4+ and CD8+ T cells, B cells, dendritic cells and neutrophils in the thymus, lymph node or spleen in healthy adult mice 22 . Whether the absence of DPP9 enzymatic activity affects short-term and long-term repopulation of immune cells of the lymphoid or myeloid lineages is underexplored.
Hematopoiesis is critically dependent upon hematopoietic stem cells (HSC). HSC migrate into the fetal liver between embryonic day (ED) 11 and 12 whereupon their numbers expand substantially 23, 24 . Between ED 13.5 and 14.5, the fetal liver contains large numbers of hematopoietic foci with erythropoiesis constituting a major part of their activity but also with capacity for myelopoiesis and lymphopoiesis 25 . A successful short-term primary engraftment (30 to 60 days) can provide confirmation that the progenitor cell pool is intact and that all myeloid and lymphoid cell types are present and, in the long term (4 months) whether the reconstituted HSC are functional [26] [27] [28] .
However, even successful long-term engraftment in a primary transplant recipient does not rule out defects in self-renewal or proliferation capability. Hence, a further serial transplant is often undertaken in chimera studies to demonstrate intact HSC engraftment and renewal 27 .
Post-transplant, identifying the progeny of the transplanted HSC is important to ascertain the effectiveness of the original graft and the properties of the regenerating immune system. The most commonly used method to achieve this is through the CD45 allelic model, where genetic differences in CD45 (CD45.1 and CD45.2) between donor and recipient mouse strains enable donor-derived cells to be traced by flow cytometry 26, 29 . Neutrophils and macrophages are the first cell types to recover after combined myelo-ablative irradiation and fetal liver or adult bone marrow cell transplant. These cells appear in the first few days after transplant, followed closely by B cells. Platelets and red blood cell lineages are present in the peripheral circulation at one to two weeks post-irradiation 27 . A small proportion of host T cells resist the effects of irradiation and expand in the post-irradiated environment, and can be detected within three weeks of transplant, while donor T cells usually become detectable 4 to 5 weeks after transplantation 29 .
Very recently, an independent study found that ED 17.5 fetal liver-derived hematopoietic stem cells from a similar DPP9 S729A mouse 16, 17 are able to fully reconstitute immune cell subsets 6 weeks after transplant in competitive mixed chimeras 30 . Here, we have explored the role of DPP9 enzyme activity in immune cell development through the creation of two sequential chimeras using ED 13.5 to 14.5 fetal liver cells and using adult bone marrow cells of WT and DPP9 S729A origin. Both short-term (6 weeks) and long-term (4 months) hematopoietic regeneration were analyzed.
Materials and Methods

Ethics statement
All animal handling and experimental procedures were approved by Sydney Local Health District Animal Welfare Committee under ethics protocol 2013/017 (K75/5-2012/3/5754), and conducted in accordance with all applicable laws and guidelines. A body scoring system was used recording details for each mouse of posture, activity and gait, breathing, hydration, the presence of abnormal excreta, body condition and body weight as compared to the baseline weight. A weight loss of greater than 15% compared to original weight triggered euthanasia of the mouse.
Mice
Mice were maintained in the Centenary Institute animal facility under specific pathogen free conditions and exposed to a 12 h light-dark cycle. C57BL/6J and PTPRCA mice were purchased from either Animal Resource Centre (Perth, WA, Australia) or Australian BioResources (Moss Vale, NSW, Australia). Mice were housed 4-6 mice per cage with ad libitum access to rodent chow (Specialty Feeds, Perth, West Australia) and water and entered experiments more than one week after any transport. All the mice used for chimera experiments were at least 8 weeks old before irradiation.
The DPP9 S729A mouse strain has been described 15 . All embryos required for fetal liver cells were obtained from pregnant females where pregnancy resulted from timed mating of DPP9 heterozygous intercrosses. For mating, single females were placed in the male home cage for 12 h then checked for the presence of a vaginal plug as an indicator of mating prior to separation from the male. The time of separation of female and male was designated ED 0.5. Females were weighed at ED 0.5 and weighed daily from ED 4.5 until ED 13. Pregnancy was suggested by weight gain greater than nonpregnant between ED 7.5 and ED 13.5 31 .
Generation of fetal liver chimeras
Primary chimeras were generated using donor-derived fetal liver cells 26 . Liver cells from embryonic mouse livers at ED13.5 -ED14.5 from DPP9 S729A and DPP9-wildtype Inc. Ontario, Canada) administered 4 h apart as previously described 32 . For fetal liver cell transplant, 2 x 10 6 cells at a volume of 200 μL per recipient mouse was injected via the lateral tail vein into recipient mice 3-4 h after irradiation. Post-transplantation, mice were provided with antibiotic in water for 14 days and monitored daily.
Generation of bone marrow chimeras
Bone marrow (BM) was prepared and transplanted as previously 32 . Secondary chimeras were produced by transferring regenerated BM donor cells from adult primary chimeric mice into new irradiated recipient mice. Nineteen 10 week-old male PTPRCA mice received one dose of a 750 rad exposure of myelo-ablative radiation as described above. The donors were two healthy DPP9 S729A -origin primary chimeric mice and two DPP9-WT-origin primary chimeric mice (all carrying the CD45.2 allele).
Each pair of selected donor mice had shared a cage but the chimerism in each mouse was produced with a different batch of fetal liver cells. BM cells from these four mice, along with two control male PTPRCA mice, were harvested. BM were released from the femur, tibia and fibula, rinsed and filtered through a 70 μm and then a 40 μm filter.
Cell suspension was centrifuged at 300 x g for 5 min at 4°C and the pellet resuspended in HBSS. For bone marrow transplant, 6.7 x 10 6 primary chimera bone marrow cells and 10 x 10 6 competitor bone marrow cells (carrying the CD45.1 allele) from PTPRCA mice (ratio of donor : competitor = 40% : 60%) at a volume of 200 μL per recipient mouse were injected via the lateral tail vein into recipient mice 3-4 h after irradiation. Post-transplantation, mice were provided with antibiotic water for 14 days and monitored daily.
Flow cytometry
For analysis of fetal liver cells, cell aliquots were thawed and red blood cells were lysed (8.26 g ammonium chloride, 1 g potassium bicarbonate and 0.037 g EDTA dissolved in 1 L of dH2O). After centrifugation and washing, cell pellet was resuspended in 200 μL of FACS wash. Then 100 μL of stain cocktail containing TER-119-APC and CD11b-FITC antibodies ( Table 1 ) was added and incubated on ice for 1 h. For analysis of peripheral blood, 5-6 drops of blood from tail vein were collected into an Eppendorf containing 50 μL 0.1M EDTA. After red blood cell lysis, cells were pelleted and resuspended in 200 μL FACS wash. Then 100 μL of stain cocktail containing a number of antibodies to identify immune cell populations represented in a reconstituted immune system (Table 1 ) was added and incubated on ice for 1 h. Just prior to flow analysis, cells were filtered and DAPI was added (100 ng/mL). Flow cytometry data were acquired using a BD LSR Fortessa cytometer (BD Pharmingen) and subsequently analyzed with FlowJo 10 software (Treestar Inc., Ashland, OR, USA).
Gating strategies are shown in Supplementary Figures 1-4 . Data were then analyzed by non-parametric Mann-Whitney U test using GraphPad Prism (GraphPad v. 9.9, San Diego, CA, USA).
Results
Hematopoietic stem cells in the fetal liver are unaltered by DPP9 genotype
Fetal liver cells were used as donor cells for primary bone marrow reconstitution chimeras because DPP9 S729A mice die within 24 h of birth [15] [16] [17] 
DPP9 S729A fetal liver cells reconstitute the immune system of irradiated mice
Primary chimeras were generated using fetal liver cells from DPP9-WT and DPP9 S729A mice. Peripheral blood was taken at 6 and 16 weeks post-transplantation for flow cytometry analyses of peripheral blood leukocytes, representative of short-term and long-term immune compartment regeneration, respectively.
Donor cell survival and hematopoietic replenishment in primary chimeric mice
Mice transplanted with DPP9-WT or DPP9 S729A fetal liver cells showed no significant differences in either mean weight or mean percentage weight change throughout the experimental period (Supplementary Figure 5 
Identification of myeloid cell types in primary chimeric mice
To examine the development and repopulation of hematopoietic lineages, the major myeloid and lymphoid cell types were analyzed. Comparison was made between DPP9-WT-origin and DPP9 S729A -origin chimeras as well as normal peripheral blood leukocytes data for C57BL/6 mice 36 . Here we assessed two major lineages: Ly6G+ neutrophils and CD3-CD19-NK1.1-Ly6G-CD11b+ myeloid cells (which are predominantly monocytes; data not shown). There were no significant differences observed between the WT and DPP9 S729A cell-origin recipient mice for either timepoint for either total myeloid cells or neutrophils ( Figure 3A ), suggesting that carrying the mutant DPP9 allele does not significantly alter hematopoietic regeneration in primary chimeric mice.
There was a clear decrease in myeloid cells between 6 and 16 weeks posttransplantation ( Figure 3A) . This decrease was similar in both genotype-origins, and is consistent with changes that are known to occur between short-term and long-term regeneration after irradiation and donor engraftment 37 . By 16 weeks, myeloid cell levels were comparable to those found in normal mouse peripheral blood 36 .
Neutrophils normally represent the largest percentage of myeloid cells, at approximately 30% in mouse. Neutrophils of the primary chimera were ~20% at 6 weeks and decreased to ~12% at 16 weeks post-transplantation, with no significant difference between genotype-origins ( Figure 3A) .
Identification of lymphoid cell types in primary chimeric mice
In these analyses, we assessed the major lymphoid lineages, namely CD3 + T cells, CD19 + B cells, and NK1.1 + natural killer (NK) cells. NK cells, which contribute to the early detection of virus-infected and cancer cells, are important for defense against pathogens and regain normal cell numbers and function within a month of transplantation 28, 38, 39 . In the primary chimeric mice, no significant difference in NK cell numbers was observed between different genotype-origin groups or between 6 and 16 weeks post-transplantation ( Figure 3B ). These data suggest that once reestablished in the peripheral blood, NK cell numbers were stable.
As reappearance of B cells is an early event occurring in the first few days after engraftment, the percentage of total B cells amongst the total lymphoid donor cells was expected to have reached a stable level by 6 weeks post-transplantation. This was the case for peripheral blood leukocytes at 6 weeks, although there were fewer B cells present in the DPP9 S729A -origin cells compared to WT-origin cells ( Figure 3B ). At 16 weeks post-transplantation, the B cell numbers for both genotype-origin groups of mice were similar ( Figure 3B ) and consistent with normal peripheral blood B cell percentages 36 .
Residual T cells of recipient origin, which is the cell type most resistant to irradiation, can be readily detectable within the first three weeks. Donor-derived T cells become readily detectable 4 to 5 weeks post-transplant 29 . Since the primary chimeric mice received a lethal dose of myelo-ablative radiation, few residual recipient T cells were expected to survive. Concordantly, few donor T cells were detected 6 weeks posttransplantation ( Figure 3B ). T cell numbers significantly increased over time, reaching ~10% of peripheral blood leukocytes at 16 weeks post-transplantation. As T cells comprise about 20% of peripheral blood leukocytes in normal mice 36 , full reconstitution of the T cell complement was perhaps not attained at 16 weeks posttransplantation in any of the mice. No significant difference in T cell numbers was observed between the WT and DPP9 S729A cell-origin recipient mice.
Secondary chimeric mice of DPP9 S729A -origin displayed an enhanced engraftment ability and an unimpaired capacity for self-renewal and proliferation
Successful long-term engraftment in a primary cell transplant recipient does not rule out defects in self-renewal capability. Hence, further serial transplants are often undertaken in studies of chimeras, in order to detect defects in HSC self-renewal capacity and the capacity for proliferation 26 . Therefore, a second set of chimeric mice was generated, in which irradiated WT hosts received BM cells from primary chimeric mice along with BM cells from congenic PTPRC A mice as competitor cells. As the result of the secondary engraftment was unknown before commencement of the experiment, competing donor cells and sub-lethal recipient irradiation were used to ensure successful cellular engraftment, immune regeneration and survival of the recipient mice 27 .
Both mouse groups, which respectively received BM from the DPP9-WT-origin and DPP9 S729A -origin primary chimeric mice, showed a similar pattern of weight loss and gain throughout 13 weeks of weight monitoring (Supplementary Figure 6 ). Return to start weight after initial weight loss was achieved in a much shorter time frame (about 2 weeks post-transplantation) than for the primary chimeric mice (4-5 weeks posttransplantation). This is consistent with the sub-lethal irradiation dose administered to the secondary mice whereas the primary mice received a higher-dose lethal myeloablative treatment.
Donor cell survival and replenishment in secondary chimeric mice
Irradiated mice were transplanted with DPP9 S729A -origin and DPP9-WT-origin primary chimeric mouse BM cells along with PTPRC A adult BM cells in the ratio of 60:40 (donor:competitor). As both competitor cells and recipient cells carried the CD45.1 allele, it was not possible to differentiate between these two sources of cells. Donor cells, however, all carried the CD45.2 allele and so could be clearly identified.
At both 6 and 16 weeks post-transplantation, the ratio of donor cells to competitor cells in WT-origin mice was 20:80 where the 80% includes residual recipient cells that survived irradiation ( Figure 4A ). This shows a dominance of competitor and residual recipient cells over donor cells, possibly due to increased numbers of residual recipient cells after sub-lethal irradiation. Interestingly, for the DPP9 S729A -origin groups, at both time-points, the ratio of donor to competitor (with residual recipient) cells more closely aligned to the original transplanted cell ratio (40:60, Figure 4A ), suggesting that the DPP9 S729A -origin donor cells had an enhanced engraftment ability. The ratio of donor to competitor cells did not alter between 6 and 16 weeks post-transplantation.
Proportions of individual cell populations are presented for each mouse ( Figure 4B ).
Increased proportions of DPP9 S729A -origin cells occurred across all lineages,
suggesting better engraftment of HSC rather than improved competition by specific cell subsets.
Identification of myeloid cell phenotypes in secondary chimeric mice
No differences in myeloid cell populations were observed between WT-origin and DPP9 S729A -origin groups, at 6 or 16 weeks post-transplantation ( Figure 5A ). In a similar pattern to that seen in the primary chimeric mice, myeloid cell percentages showed a significant reduction from 6 to 16 weeks post-transplantation ( Figure 5A ). Myeloid cell percentages at 6 weeks were lower in the secondary chimera (~ 25%) compared to the primary chimera (~ 30%). Perhaps associated with this, the reduction in myeloid cell percentages at 16 weeks was less pronounced in the secondary than in the primary chimera. Similar to the primary chimera, approximately 60% of myeloid cells in each genotype were neutrophils at 6-weeks post-transplantation ( Figure 5A ). At 16 weeks, however, this proportion was approximately 50% for each genotype, and this difference was significant for DPP9 S729A -origin cells. Perhaps at 16 weeks there was a less intense irradiation-induced inflammatory response in the secondary compared to the primary chimera, or a more rapid resolution of that response, such that at 16 weeks the myeloid cell compartment was normalised from a neutrophil-biased state to encompass other granulocyte cell types.
Identification of lymphoid cell phenotypes in secondary chimeric mice
In secondary chimeric mice, the main lymphoid lineage cell subsets were present and were not significantly different in abundance between genotypes ( Figure 5B ). As with the primary chimera, the B cell percentages were consistent with those normally observed in mouse peripheral blood leukocytes 36 . In contrast to the primary chimeric mice, T cell percentages were approximately 11% at both 6 and 16 weeks posttransplantation in each chimera. This was less than the expected level of 20% T cells in peripheral blood leukocytes.
Considering the overall peripheral blood leukocytes of both myeloid and lymphoid lineage, the trend in the primary chimeric mice from 6 to 16-weeks post-transplant was towards a greater proportion of lymphoid cells ( Figure 6A ). This is consistent with a change from unlimited self-renewal ability by HSC towards a limited self-renewal ability as the regenerating immune system changes from short term to long term reconstitution 40 . For the secondary chimeras, the peripheral blood leukocytes of both myeloid and lymphoid lineages were similar at 6 and 16 weeks post-transplant, with a strong bias towards the lymphoid lineages ( Figure 6B ).
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Discussion
We created chimeric mice using fetal and adult donor cells with both normal and absent DPP9 enzymatic activity. We showed that a lack of DPP9 enzymatic activity in HSC does not impair their ability to engraft in irradiated mice or to repopulate all major immune cell types in the regenerated immune system in primary or secondary chimeras. Interestingly, secondary chimeric mice were efficiently engrafted by blood immune cell precursors lacking DPP9 enzymatic activity. Our data broadly concord with data from an independently-derived DPP9 S729A mouse 41 . That study examined only primary chimeras and only at 6 weeks and used ED 17.5 rather than ED 13.5 fetal liver. Importantly, the data from both that study and our study are consistent with outcomes current knowledge of normal engraftment by fetal liver cells 36, 37, 39 , and so equally suggest that lacking DPP9 does not impair engraftment. Live/dead cells in PBL were gated using DAPI staining and then autofluorescent cells were excluded at 565nm, 582nm and 610nm. Then CD45.1 positive recipient cells and CD45.2 positive donor cells were identified. CD11b and CD3e were markers of myeloid cells and T cells, respectively. Ly6G and CD19 were markers of neutrophils and B cells, respectively. Representative data from DPP9-WT-origin chimeric mice 16 weeks after irradiation.
Figure S3: Flow cytometry gating strategy for identifying NK cells.
CD45.2 positive donor cells were identified in PBL as described in Figure S2 . The markers CD3e and CD19 were used to identify the CD3e -CD19cell subset that includes NK cells. The markers CD8a and NK1.1 were then used to identify NK
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Figure S4: Body weight: primary chimeras.
Irradiated mice inoculated with DPP9 S729A or DPP9-WT fetal liver cells were monitored for weight loss as a gross indicator of dysfunctional or failed immune regeneration. All irradiated mice exhibited an initial weight loss for several days before gradual weight increase back to the original start weight at around 4-5 weeks post-transplantation. Mean body weight of mice (A), and mean percentage weight change where 0 (red dotted line) represents the body weight immediately before irradiation (B). n = 7 mice per group.
Figure S5: Body weight: secondary chimeras.
Irradiated mice inoculated with DPP9 S729A (n = 10) or DPP9-WT (n = 9) bone marrow cells along with PTPRC A WT bone marrow cells were monitored for weight loss as a gross indicator of dysfunctional or failed immune regeneration. All irradiated mice displayed an initial weight loss for several days before gradual weight increase, returning to the original weight by 2 weeks after irradiation. Mean body weight of mice (A), and mean percentage weight change where 0 (red dotted line) represents the body weight immediately before irradiation (B).
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